|Articles|July 20, 2016

JSS Selects OmniComm TrialMaster EDC

OmniComm Systems announces a three-year agreement with Montreal-based CRO JSS Medical Research.

OmniComm Systems announces a three-year agreement with Montreal-based CRO JSS Medical Research. OmniComm’s TrialMaster platform will be used for the collection of data in numerous clinical trials across global investigative sites.

Read the full release here

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

JSS Selects OmniComm TrialMaster EDC

Related Content

Why Payment Performance Has Become an Operational Brand for Sponsors: Q&A with Patrick Mizer, Ledger Run

What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale

ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD

Beyond Patient Centricity: What Rare Disease Research Gets Right

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

Trending on Applied Clinical Trials Online

Beyond Patient Centricity: What Rare Disease Research Gets Right

What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale

ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files